Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
In The Press
Proteomics Tools: A Resurrection
Next-generation tools, from spatial proteomics to high-plex affinity assays, are reviving proteomics and unlocking the proteome as a scalable layer of biology.
March 11, 2026
In The Press
Proteomics Tools: A Resurrection
Next-generation tools, from spatial proteomics to high-plex affinity assays, are reviving proteomics and unlocking the proteome as a scalable layer of biology.
March 11, 2026
Proteomics Market
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | February Round-Up 2026
Liquid Biopsy (LBx) continued to develop through February, featuring new clinical and research collaborations, many study results and trial launches, and M&A updates.
March 10, 2026
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | February Round-Up 2026
Liquid Biopsy (LBx) continued to develop through February, featuring new clinical and research collaborations, many study results and trial launches, and M&A updates.
March 10, 2026
Liquid Biopsy
.png)
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | February Round-Up 2026
Read about the latest updates in the Next-Generation Therapeutics space in the month of February.
March 5, 2026
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | February Round-Up 2026
Read about the latest updates in the Next-Generation Therapeutics space in the month of February.
March 5, 2026
Next-Generation Therapeutics
%20(1).png)
Blog Article
Pharma & Biotech
Decoding Global Pharma Strategy Through UK Biotech M&A Trends (2010–2026)
UK biotech M&A reveals Big Pharma’s shift from risky early-stage bets to premium-priced, revenue-ready acquisitions as the patent cliff looms.
February 26, 2026
Blog Article
Pharma & Biotech
Decoding Global Pharma Strategy Through UK Biotech M&A Trends (2010–2026)
UK biotech M&A reveals Big Pharma’s shift from risky early-stage bets to premium-priced, revenue-ready acquisitions as the patent cliff looms.
February 26, 2026
pharma
Webinar
Research Tools
Building Cell Therapies That Scale Webinar
A pragmatic, post-JPM and post-ATW look at the state of cell therapy development, from LVV design to CMC realities and scientific decision-making.
February 19, 2026
Webinar
Research Tools
Building Cell Therapies That Scale Webinar
A pragmatic, post-JPM and post-ATW look at the state of cell therapy development, from LVV design to CMC realities and scientific decision-making.
February 19, 2026
Cell & Gene Tx
Blog Article
Financial Services
Women’s Health Is the Longevity Platform Hiding in Plain Sight
As focus shifts from lifespan to health span, a real question emerges: will value remain fragmented across well-capitalized point solutions, or concentrate in a handful of platforms that specialize in personalizing medicine across women’s life stages?
February 18, 2026
Blog Article
Financial Services
Women’s Health Is the Longevity Platform Hiding in Plain Sight
As focus shifts from lifespan to health span, a real question emerges: will value remain fragmented across well-capitalized point solutions, or concentrate in a handful of platforms that specialize in personalizing medicine across women’s life stages?
February 18, 2026
Women's Health
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved